Food Effect Study in Healthy Volunteers
← catalyst calendarSponsored by Biomea Fusion Inc. (industry) · BMEA — their whole pipeline →.
Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
60actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-09-11 | actual | When the study began enrolling |
| Primary completion | 2026-01-14 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-01-14 | actual | The whole study's end, after follow-up |
| First posted | 2025-11-28 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-11 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Volunteer
Interventions
- Drug: Icovamenib — also filed as BMF-219
- Drug: Icovamenib HPMC — also filed as BMF-219 HPMC
Primary outcomes
what the primary-completion date above is the date OFEvaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Every other day for a max of 2 weeks
Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Every other day for a max of 2 weeks
Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Every other day for a max of 2 weeks
Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Every other day for a max of 2 weeks
Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Every other day for a max of 2 weeks
Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Every other day for a max of 2 weeks
Evaluate food effect and PK profile of icovamenib capsule formulation in fed and fasted states
measured Time Frame: Every other day for a max of 2 weeks
Permalink · BMEA's whole pipeline · Catalyst calendar · Every registered study · What changed